Boston Family Office’s Colgate-Palmolive CL Stock Holding History

Boston Family Office’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$669K	Hold	7,853	–	–	0.04%	196
2025 Q4	$621K	Hold	7,853	–	–	0.04%	194
2025 Q3	$628K	Hold	7,853	–	–	0.04%	194
2025 Q2	$714K	Sell	7,853 -107	-1%	-$9.77K	0.05%	182
2025 Q1	$746K	Buy	7,960 +1,400	+21%	+$125K	0.05%	176
2024 Q4	$596K	Hold	6,560	–	–	0.04%	182
2024 Q3	$681K	Hold	6,560	–	–	0.05%	177
2024 Q2	$637K	Hold	6,560	–	–	0.05%	174
2024 Q1	$591K	Sell	6,560 -15	-0.2%	-$1.27K	0.04%	175
2023 Q4	$524K	Sell	6,575 -170	-3%	-$12.8K	0.04%	189
2023 Q3	$480K	Sell	6,745 -135	-2%	-$10.1K	0.04%	187
2023 Q2	$530K	Sell	6,880 -22	-0.3%	-$1.7K	0.04%	185
2023 Q1	$518K	Sell	6,902 -24,184	-78%	-$1.8M	0.04%	186
2022 Q4	$2.45M	Hold	31,086	–	–	0.2%	92
2022 Q3	$2.18M	Sell	31,086 -410	-1%	-$32.1K	0.19%	94
2022 Q2	$2.52M	Sell	31,496 -40	-0.1%	-$3.13K	0.21%	94
2022 Q1	$2.39M	Sell	31,536 -50	-0.2%	-$3.96K	0.17%	105
2021 Q4	$2.7M	Hold	31,586	–	–	0.18%	102
2021 Q3	$2.39M	Sell	31,586 -1,355	-4%	-$108K	0.17%	104
2021 Q2	$2.68M	Sell	32,941 -370	-1%	-$30.3K	0.19%	102
2021 Q1	$2.63M	Hold	33,311	–	–	0.2%	101
2020 Q4	$2.85M	Hold	33,311	–	–	0.22%	96
2020 Q3	$2.57M	Sell	33,311 -300	-0.9%	-$22.9K	0.23%	89
2020 Q2	$2.46M	Hold	33,611	–	–	0.24%	94
2020 Q1	$2.23M	Sell	33,611 -50	-0.1%	-$3.53K	0.26%	88
2019 Q4	$2.32M	Hold	33,661	–	–	0.22%	100
2019 Q3	$2.47M	Sell	33,661 -394	-1%	-$28.6K	0.26%	93
2019 Q2	$2.44M	Hold	34,055	–	–	0.25%	92
2019 Q1	$2.33M	Sell	34,055 -9,056	-21%	-$585K	0.25%	95
2018 Q4	$2.57M	Sell	43,111 -6,786	-14%	-$425K	0.32%	85
2018 Q3	$3.34M	Buy	49,897 +50	+0.1%	+$3.33K	0.35%	84
2018 Q2	$3.23M	Sell	49,847 -100	-0.2%	-$6.54K	0.37%	82
2018 Q1	$3.58M	Hold	49,947	–	–	0.41%	78
2017 Q4	$3.77M	Sell	49,947 -4,900	-9%	-$358K	0.41%	77
2017 Q3	$4M	Sell	54,847 -400	-0.7%	-$28.8K	0.45%	73
2017 Q2	$4.09M	Sell	55,247 -836	-1%	-$62.1K	0.48%	70
2017 Q1	$4.11M	Sell	56,083 -380	-0.7%	-$26.6K	0.5%	67
2016 Q4	$3.69M	Sell	56,463 -604	-1%	-$41.4K	0.48%	68
2016 Q3	$4.23M	Sell	57,067 -44	-0.1%	-$3.25K	0.55%	61
2016 Q2	$4.18M	Sell	57,111 -70	-0.1%	-$4.98K	0.54%	60
2016 Q1	$4.04M	Sell	57,181 -150	-0.3%	-$9.98K	0.53%	61
2015 Q4	$3.82M	Buy	57,331 +27	+0%	+$1.8K	0.52%	65
2015 Q3	$3.64M	Hold	57,304	–	–	0.51%	68
2015 Q2	$3.75M	Sell	57,304 -200	-0.3%	-$13.6K	0.47%	70
2015 Q1	$3.99M	Sell	57,504 -2,200	-4%	-$152K	0.5%	68
2014 Q4	$4.13M	Sell	59,704 -940	-2%	-$63.5K	0.51%	66
2014 Q3	$3.96M	Buy	60,644 +3,450	+6%	+$228K	0.51%	67
2014 Q2	$3.9M	Buy	57,194 +400	+0.7%	+$26.8K	0.49%	65
2014 Q1	$3.68M	Sell	56,794 -75	-0.1%	-$4.73K	0.49%	69
2013 Q4	$3.71M	Buy	56,869 +1,030	+2%	+$65.9K	0.49%	70
2013 Q3	$3.31M	Sell	55,839 -205	-0.4%	-$12.1K	0.47%	71
2013 Q2	$3.21M	Buy	+56,044	New	+$3.33M	0.49%	71

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Boston Family Office's CL Position: Q1 2026 in Review

Boston Family Office held its Colgate-Palmolive (CL) position steady in Q1 2026 at 7,853 shares worth $669K. The position accounts for 0.04% of the portfolio, ranked #196.

Boston Family Office first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.23M in Q3 2016. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Boston Family Office held 7,853 shares of Colgate-Palmolive worth $669K as of Q1 2026.
Boston Family Office left its Colgate-Palmolive share count unchanged in Q1 2026.
Colgate-Palmolive made up 0.04% of Boston Family Office's portfolio in Q1 2026, its #196 holding.
Boston Family Office first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
Boston Family Office's Colgate-Palmolive position peaked at $4.23M in Q3 2016.
1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Boston Family Office's 13F filing for Q1 2026, filed 13 May 2026.